Sign In
Buy KMDA
$7.39
-0.120 (-1.60%)
At Close: Jun 03, 2026
Compared to Estimates, Kamada (KMDA) Q1 Earnings: A Look at Key Metrics
10:30am, Wednesday, 14'th May 2025
While the top- and bottom-line numbers for Kamada (KMDA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to
Kamada (KMDA) Q1 Earnings Match Estimates
09:10am, Wednesday, 14'th May 2025
Kamada (KMDA) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago.
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability
07:00am, Wednesday, 14'th May 2025
REHOVOT, Israel and HOBOKEN, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ra
Kamada (KMDA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:20am, Friday, 09'th May 2025
Besides Wall Street's top -and-bottom-line estimates for Kamada (KMDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
07:00am, Wednesday, 19'th Mar 2025
REHOVOT, Israel and HOBOKEN, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for
Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript
11:06am, Wednesday, 05'th Mar 2025
Kamada Ltd. (NASDAQ:KMDA ) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Brian Ritchie – LifeSci Advisors Amir London – Chief Executive Officer Chaime Orlev – Ch
Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth
07:05am, Wednesday, 05'th Mar 2025
REHOVOT, Israel, and HOBOKEN, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for
Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
07:00am, Wednesday, 26'th Feb 2025
REHOVOT, Israel, and HOBOKEN, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd.
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
07:00am, Wednesday, 22'nd Jan 2025
REHOVOT, Israel and HOBOKEN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for r
Kamada Ltd. (KMDA) Q3 2024 Earnings Call Transcript
09:54am, Wednesday, 13'th Nov 2024
Call Start: 08:30 January 1, 0000 9:52 AM ET Kamada Ltd. (NASDAQ:KMDA ) Q3 2024 Earnings Conference Call November 13, 2024, 08:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors Amir Londo
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston
07:00am, Monday, 23'rd Sep 2024
REHOVOT, Israel and HOBOKEN, N.J., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for
Kamada Ltd. (KMDA) Q2 2024 Earnings Call Transcript
01:45pm, Wednesday, 14'th Aug 2024
Kamada Ltd. (NASDAQ:KMDA ) Q2 2024 Earnings Conference Call August 14, 2024 8:30 AM ET Company Participants Troy Williams - LifeSci Advisors Amir London - Executive Officer Chaime Orlev - Chief Financ
Kamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024
07:00am, Wednesday, 07'th Aug 2024
REHOVOT, Israel, and HOBOKEN, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed produc
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
03:04pm, Monday, 29'th Jul 2024
What could be better than viable enterprises within the biotechnology industry? Try biotech stocks under $10.
Kamada Ltd. (KMDA) Q1 2024 Earnings Call Transcript
11:55am, Wednesday, 08'th May 2024
Kamada Ltd. (NASDAQ:KMDA ) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors, LLC Amir London - Executive Officer Chaime
